A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants

Clinical trial NCT07588139 · RECRUITING

Trial details

NCT number: NCT07588139
Sponsor: Incyte Corporation
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2026-05-18
Primary completion: 2026-09-03
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.